feed,title,long_url,short_url
BioRxiv,Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells,https://biorxiv.org/cgi/content/short/2020.12.09.416586v1?rss=1,https://j.mp/370hLZF
BioRxiv,Complete Protection of Nasal and Lung Airways Against SARS-CoV-2 Challenge by Antibody Plus Th1 Dominant N- and S-Specific T-Cell Responses to Subcutaneous Prime and Thermally-Stable Oral Boost Bivalent hAd5 Vaccination in an NHP Study,https://biorxiv.org/cgi/content/short/2020.12.08.416297v1?rss=1,https://j.mp/2W16XEx
BioRxiv,Persistent Cellular Immunity to SARS-CoV-2 Infection,https://biorxiv.org/cgi/content/short/2020.12.08.416636v1?rss=1,https://j.mp/3oEcblI
BioRxiv,Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases,https://biorxiv.org/cgi/content/short/2020.12.08.416750v1?rss=1,https://j.mp/2Lo3wpm
